AZRX AzurRx BioPharma Inc.

1.04
+0.04  (+4%)
Previous Close 1
Open 1
Price To Book 9.46
Market Cap 27,147,571
Shares 26,103,434
Volume 29,124
Short Ratio
Av. Daily Volume 275,141

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data due September 2019.
MS1819-SD (OPTION)
Cystic fibrosis
Phase 2 data due early 2020.
MS1819-SD
Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency